VP16 - 213（依托泊苷）用于难治性转移性乳腺癌的II期研究。 - Suppr

Suppr

超能文献

Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.

作者信息

Schell F C, Yap H Y, Hortobagyi G N, Issell B, Esparza L

出版信息

Cancer Chemother Pharmacol. 1982;7(2-3):223-5. doi: 10.1007/BF00254555.

DOI:10.1007/BF00254555

PMID:7083463

Abstract

摘要

相似文献

Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.VP16 - 213（依托泊苷）用于难治性转移性乳腺癌的II期研究。

Cancer Chemother Pharmacol. 1982;7(2-3):223-5. doi: 10.1007/BF00254555.

Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.

Cancer Chemother Pharmacol. 1982;7(2-3):231-3. doi: 10.1007/BF00254557.

VP16-213 and cyclophosphamide in advanced breast cancer. A phase II study.

Cancer Chemother Pharmacol. 1983;10(3):154-7. doi: 10.1007/BF00255751.

Mitomycin-C, VP16-213 combination as third line chemotherapy in advanced breast cancer.

Cancer Chemother Pharmacol. 1982;7(2-3):227-9. doi: 10.1007/BF00254556.

Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.依托泊苷治疗晚期或复发性子宫内膜癌的II期试验：一项妇科肿瘤学组研究

Cancer Treat Rep. 1982 Aug;66(8):1669-71.

Phase II study of etoposide in the treatment of esophageal carcinoma.

Cancer Treat Rep. 1983 Apr;67(4):397-8.

Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.依托泊苷用于难治性多发性骨髓瘤的II期评估：一项东南癌症研究组试验

Cancer Treat Rep. 1986 Jun;70(6):801-2.

Multicenter Phase II trial of etoposide in refractory small cell lung cancer.

Cancer Treat Rep. 1985 Jan;69(1):127-8.

Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agents.

Gynecol Oncol. 1978 Feb;6(1):7-9. doi: 10.1016/0090-8258(78)90002-1.

Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.

Cancer Treat Rep. 1983 May;67(5):509-10.

引用本文的文献

Efficacy of oral Etoposide in pretreated metastatic breast cancer: a multicenter phase 2 study.口服依托泊苷治疗经治转移性乳腺癌的疗效：一项多中心2期研究。

Medicine (Baltimore). 2015 May;94(17):e774. doi: 10.1097/MD.0000000000000774.

Chronic oral etoposide in advanced breast cancer.晚期乳腺癌的慢性口服依托泊苷治疗

Cancer Chemother Pharmacol. 1994;33(6):527-9. doi: 10.1007/BF00686513.

Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer.

Breast Cancer Res Treat. 1995 May;34(2):185-9. doi: 10.1007/BF00665790.

Hypersensitivity reactions from antineoplastic agents.抗肿瘤药物引起的超敏反应。

Cancer Metastasis Rev. 1987;6(3):413-32. doi: 10.1007/BF00144273.

Phase II study with etoposide in previously untreated advanced breast cancer.

Cancer Chemother Pharmacol. 1989;24(4):261-3. doi: 10.1007/BF00257630.

Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.依托泊苷。对其药效学和药代动力学特性以及在癌症联合化疗中的治疗潜力的综述。

Drugs. 1990 Mar;39(3):438-90. doi: 10.2165/00003495-199039030-00008.

Phase I-II study of high-dose etoposide in patients with refractory breast cancer.

Invest New Drugs. 1991 Nov;9(4):365-7. doi: 10.1007/BF00183583.

本文引用的文献

Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer.长春花碱以连续5天输注的方式用于治疗难治性晚期乳腺癌。

Cancer Treat Rep. 1980 Feb-Mar;64(2-3):279-83.

Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors.

Eur J Cancer (1965). 1973 Mar;9(3):215-21. doi: 10.1016/s0014-2964(73)80021-0.

The chemical therapy of breast cancer.乳腺癌的化学疗法。

Semin Oncol. 1974 Jun;1(2):131-44.

Combination chemotherapy for advanced breast cancer: response and effect on survival.

Ann Intern Med. 1976 Apr;84(4):389-92. doi: 10.7326/0003-4819-84-4-389.

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer.

Cancer. 1975 Jul;36(1):90-7. doi: 10.1002/1097-0142(197507)36:1<90::aid-cncr2820360104>3.0.co;2-h.

Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.阿霉素加长春新碱与环磷酰胺、甲氨蝶呤和5-氟尿嘧啶联合用于晚期乳腺癌的比较及联合应用。

Cancer. 1975 Apr;35(4):1108-15. doi: 10.1002/1097-0142(197504)35:4<1108::aid-cncr2820350414>3.0.co;2-z.

Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapy.

Cancer. 1978 Feb;41(2):392-5. doi: 10.1002/1097-0142(197802)41:2<392::aid-cncr2820410202>3.0.co;2-7.

Chemo immunotherapy of advanced breast cancer with BCG.

Recent Results Cancer Res. 1977(62):143-50. doi: 10.1007/978-3-642-81174-6_21.

Etoposide (VP-16-213).

Cancer Treat Rev. 1979 Jun;6(2):107-24. doi: 10.1016/s0305-7372(79)80045-6.

Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer.

Cancer Treat Rep. 1979 Jan;63(1):77-83.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验